ClinicalTrials.Veeva

Menu

High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women (HICONEXOBWO)

U

University of Valladolid (UVA)

Status

Completed

Conditions

Women Veterans
Postmenopausal
Obese Women
Sedentary Lifestlye

Treatments

Behavioral: Control Group
Behavioral: concurrent training
Behavioral: High-Intensity Interval

Study type

Interventional

Funder types

Other

Identifiers

NCT07302191
2025.12.11

Details and patient eligibility

About

Introduction: Menopause is associated with body composition change, an increase in the cardio-metabolic risk factor for oxidative stress. Nevertheless, it has been suggested that regular physical training is an effective non-pharmacological intervention to reduce oxidative stress and cardio-metabolic disorders in menopausal individuals. Therefore, the present study was conducted to compare the effects of twelve weeks of high-intensity interval training (HIIT) and concurrent (Conc) and on body composition, cardio-metabolic indices and oxidative stress in sedentary obese postmenopausal women.

Materials and methods: Forty-five menopausal obese women voluntarily participated and were randomly assigned into three groups: a) HIIT (6-12×60s of high intensity training (85-95% HRMax) and then running for 60 seconds with low intensity (55-60% HRMax)), b) concurrent endurance (performed on training with 55-75% HRMax) and strength training (including two sets in eight exercise stations with 55-75% 1RM)) and c) control group. Training programs were done for twelve weeks, 3 times per week. Body composition, cardio-metabolic indices and oxidative stress markers were measured before and after twelve weeks of exercise training program.

Enrollment

58 patients

Sex

Female

Ages

50 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with at least 12 months of amenorrhea.
  • Physical abilities with the capacity to exercise safely as determined by a medical evaluation.
  • Women in a sedentary state, defined as performing <150 minutes of moderate to vigorous physical activity per week during the previous year.
  • BMI >25 and ≤40 kg/ m2

Exclusion criteria

  • hormone replacement therapy
  • smoking.
  • diagnosed cardiovascular, renal, or hepatic disease, uncontrolled hypertension, or any musculoskeletal limitation precluding exercise participation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

58 participants in 3 patient groups

high-intensity interval training (HIIT)
Experimental group
Description:
The HIIT group performed treadmill or overground running/walking intervals consisting of 60 s at 90-95% of maximal heart rate (HRmax), interspersed with 60 s of active recovery at 55-60% HRmax (40) HRmax was estimated individually using the Tanaka et al. equation (41) (HRmax = 208 - 0.7 × age), which has been validated in middle-aged women. Session duration ranged from approximately 25 to 35 min (excluding warm-up and cool-down).
Treatment:
Behavioral: High-Intensity Interval
Concurrent Training (CONC)
Experimental group
Description:
The CONC program integrated resistance and aerobic exercise within a single, periodized session designed to elicit both muscular and cardiovascular adaptations. Resistance component: Participants performed three sets per exercise targeting major muscle groups (leg press, chest press, seated row, shoulder press, leg curl, and abdominal crunch) with 1 min rest between sets. Training intensity progressed from 55% of one-repetition maximum (1RM) for 10-15 repetitions in week 1 to 75% 1RM for 8-12 repetitions by week 12. To ensure appropriate load progression, 1RM was reassessed every three weeks. Perceived exertion was recorded (Borg 6-20 scale), maintaining RPE 13-15 ("somewhat hard") to confirm compliance with relative intensity. Aerobic component: Participants completed 20 min of treadmill running or brisk walking, progressing from 55% HRmax in week 1 to 75% HRmax in week 12, in accordance with the protocol of Kargarfard et al. (44) and consistent with the concurrent training framework
Treatment:
Behavioral: concurrent training
Control Group
Sham Comparator group
Description:
Participants assigned to the CG were instructed to maintain their usual daily routines and to refrain from engaging in any structured exercise or new physical activity programs during the 12-week intervention period.
Treatment:
Behavioral: Control Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems